INS and diabetes mellitus: The retrospective evidence available is more controversial, with studies showing either no mortality differences in comparison to HF patients with diabetes treated with oral antidiabetic agents, or increased mortality in insulin‐requiring patients (Fitchett David et al., 2017; Gilbert & Krum, 2015).